Trityl olmesartan acid, identified by its CAS number 761404-85-7, is a chemical compound that belongs to the class of angiotensin II receptor antagonists, specifically used in the treatment of hypertension. It is a derivative of olmesartan, which is known for its ability to inhibit the action of angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing blood pressure. The trityl group in its structure enhances its lipophilicity, potentially influencing its pharmacokinetic properties. This compound typically exhibits good solubility in organic solvents and may have limited solubility in water, which is a common characteristic of many pharmaceutical compounds. Its stability under physiological conditions is crucial for its efficacy as a medication. Additionally, trityl olmesartan acid may undergo metabolic transformations in the body, leading to active metabolites that contribute to its therapeutic effects. Overall, its design aims to provide effective blood pressure management while minimizing side effects associated with antihypertensive therapies.

Trityl olmesartan acid

761404-85-7: Trityl olmesartan acid, identified by its CAS number 761404-85-7, is a chemical compound that belongs to the class of angiotensin II receptor antagonists, specifically used in the treatment of hypertension. It is a derivative of olmesartan, which is known for its ability to inhibit the action of angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing blood pressure. The trityl group in its structure enhances its lipophilicity, potentially influencing its pharmacokinetic properties. This compound typically exhibits good solubility in organic solvents and may have limited solubility in water, which is a common characteristic of many pharmaceutical compounds. Its stability under physiological conditions is crucial for its efficacy as a medication. Additionally, trityl olmesartan acid may undergo metabolic transformations in the body, leading to active metabolites that contribute to its therapeutic effects. Overall, its design aims to provide effective blood pressure management while minimizing side effects associated with antihypertensive therapies.

<p>4-(1-Hydroxy-1-methylethyl)-2-propyl-1[4-[2-(trityltetrazol-5-yl)phenyl]phenyl]methylimidazol-5-caboxylic acid (4MPPC) is a water soluble, clear liquid that is used as a solvent. It can be prepared by the reaction of sodium carbonate with an organic or inorganic salt solution in acetonitrile. The solvents are then removed using filtration and the final product is obtained by evaporation of the solvent. 4MPPC has been used in the preparation of medoxomil, which is an antibiotic that inhibits bacterial growth by binding to DNA gyrase and topoisomerase IV.</p>

CAS 761404-85-7

Trityl olmesartan acid

Trityl olmesartan acid

Ref: 3D-IH57931

Trityl Olmesartan Acid

Ref: ST-EA-CP-O7044